Go to content
Attention:

AFM Portaal en AFM-website niet bereikbaar komend weekend

Vanaf vrijdag 4 oktober 21.00 uur tot zondag 6 oktober 21.00 uur is het AFM Portaal niet bereikbaar. Vanaf zaterdag 5 oktober 06.00 uur tot zondag 6 oktober 21.00 uur is de AFM-website niet bereikbaar.

Koninklijke Philips N.V.

Koninklijke Philips N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 14 jun 2012 - 09:32
Statutaire naam Koninklijke Philips N.V.
Titel Philips commences operations at greenfield healthcare manufacturing facility in India
Bericht June 14, 2012 Philips commences operations at greenfield healthcare manufacturing facility in India Development and Manufacturing Center in Chakan, near Pune, to provide locally relevant healthcare solutions for India and other growth geographies Chakan, India - In line with its strategy to expand the company’s industrial footprint in India, Royal Philips Electronics (NYSE:PHG, AEX:PHI) today announced commencement of operations at its first greenfield manufacturing facility for imaging systems in the country. Located in Chakan, near Pune, 200 kilometers east of Mumbai, the Philips Development and Manufacturing Center will play an essential role in Philip’s commitment to locally develop and produce meaningful products and solutions that help improve access to healthcare for people in India and other growth geographies. With this multimillion euro investment, Philips has reinforced and optimized its production capacity in India. The facility will focus on diagnostic and interventional imaging solutions, initially developed for the Indian market and then for global markets. These solutions will primarily target cardiology (catheterization lab) and radiology (general X-ray) applications. The first products to be manufactured in the facility will be diagnostic X-Ray systems and the Allura FC – Philips’ first India developed catheterization lab. The Allura FC is used in the diagnosis and minimally-invasive treatment of cardiovascular disease, one of the leading causes of death in India. Both products are aimed at the value segment in India and abroad. “This plant is an example of how Philips can combine its technology strengths and market knowledge to manufacture products for a healthier India,” said Rajeev Chopra, Managing Director & Vice Chairman, Philips India. “The Pune facility is producing X-ray and cath-lab equipment backed by Philips quality that is affordable for tier-two and tier-three towns and rural markets.” The Pune facility was specifically..

Datum laatste update: 06 oktober 2024